Consulting Startups: Entrepreneurship Meets Consulting
Curious about consulting or starting a company? The Tri-I Consulting Club & Startup Venture Group are inviting you to a panel discussion with startup founders & partners in consulting. Learn about how these career paths intersect and diverge within the biopharma ecosystem.
Panelists:
John Pena earned his PhD from Rockefeller University in 2010 and his MD from Weill Cornell in 2011. He completed his residency in Ophthalmology at Weill Cornell in 2016. He founded Sonder Medicine in 2019, which uses extracellular vesicles from the vitreous humor as a potent vector to efficiently deliver recombinant proteins into the sensory tissue of the eye, the retina.
Vadim Shepel earned his BS in Economics from New York University. He has worked for a multitude of companies, including Pfizer and Concarlo Therapeutics. He founded Bench2Bio, a company which empowers biotech entrepreneurs to navigate the complex landscape of fundraising and partnerships, and is also a mentor at IndieBio.
Yue Hu received her Bachelor’s degree from Jinan University in Biomedical/Medical Engineering and Masters from Drexel University in Biomedical/Medical Engineering in 2017. She has worked in many financial roles and currently is a manager at CSPC Pharmaceutical Group. Yue co-founded Tupelo Brittany, a consulting firm specialized for pharma and biotech.
Drew Zhu received a Masters in Biotechnology from New York University and completed Harvard Business School. Drew was a research consultant at Navigant before co-founding EMW3, a company which helps brands across various industries at all stages to maximize their ROI and achieve exponential growth, and is now VP of Global Business Development at Hudson Holdings Group. Drew co-founded Tupelo Brittany with Yue.